HIV Immune and Virological Responses Following the Administration of IL-2 Either Alone or Combined to ALVAC-HIV 1433 and HIV Lipopeptides in Patients Treated Early With HAART During Primary Infection
Clinical trial NCT00196651 · TERMINATED
Trial details
- NCT number
- NCT00196651
- Sponsor
- French National Agency for Research on AIDS and Viral Hepatitis
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2000-08-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.